Abstract:Recent evidence shows that activation of microglia releases various proinflammatory cytokines and neurotoxic mediators, which plays an important role in the pathogenesis of chronic pain. Toll-like receptor 4 (TLR4) on the microglia is the main receptor on the cell membrane for the Gram-negative bacteria cell-wall component. Both nuclear factor kappa B (NF-κB) and mitogen activated protein kinases (MAPkinases) mediate production of proinflammatory cytokines in many types of cells, however, the signal pathways and relationship in details are not very clear in microglia. Here, we investigated the effects of KDO2 (a new TLR4 agonist) on the highly aggressively proliferating immortalized (HAPI) cells that had been enriched for microglia. KDO2 treatment significantly induced the phosphorylation of c-Jun N-terminal kinase (JNK) and NF-κB, but not p38, and released TNFα and IL-1β. The knockdown of TLR4 with TLR4 siRNA significantly reduced the expression of phosphorylation of JNK (pJNK) and phosphorylation of NF-κB (pNF-κB), TNFα, and IL-1β. Inhibition of JNK reduced the release of TNFα, but not phosphorylation of NF-κB. Inhibition of NF-κB reduced the release of IL-1β; unexpectedly, inhibition of NF-κB enhanced pJNK and release of TNFα. These findings showed that TNFα induced by KDO2 was JNK-dependent, and that NF-κB negatively modulated both pJNK and TNFα in the cultured microglial cells. The current study may provide a new insight in the modulation of cytokines in the microglial cells. Recent evidence shows that activation of microglia releases various proinflammatory cytokines and neurotoxic mediators, which plays an important role in the pathogenesis of chronic pain. Toll-like receptor 4 (TLR4) on the microglia is the main receptor on the cell membrane for the Gram-negative bacteria cell-wall component. Both nuclear factor kappa B (NF-κB) and mitogen activated protein kinases (MAPkinases) mediate production of proinflammatory cytokines in many types of cells, however, the signal pathways and relationship in details are not very clear in microglia. Here, we investigated the effects of KDO2 (a new TLR4 agonist) on the highly aggressively proliferating immortalized (HAPI) cells that had been enriched for microglia. KDO2 treatment significantly induced the phosphorylation of c-Jun N-terminal kinase (JNK) and NF-κB, but not p38, and released TNFα and IL-1β. The knockdown of TLR4 with TLR4 siRNA significantly reduced the expression of phosphorylation of JNK (pJNK) and phosphorylation of NF-κB (pNF-κB), TNFα, and IL-1β. Inhibition of JNK reduced the release of TNFα, but not phosphorylation of NF-κB. Inhibition of NF-κB reduced the release of IL-1β; unexpectedly, inhibition of NF-κB enhanced pJNK and release of TNFα. These findings showed that TNFα induced by KDO2 was JNK-dependent, and that NF-κB negatively modulated both pJNK and TNFα in the cultured microglial cells. The current study may provide a new insight in the modulation of cytokines in the microglial cells.

Toll-Like Receptors Promote Mitochondrial Translocation of Nuclear Transcription Factor Nuclear Factor of Activated T-Cells in Prolonged Microglial Activation

Activation of Toll-like receptor 5 in microglia modulates their function and triggers neuronal injury

TLR4 signaling pathway mediates the LPS/ischemia-induced expression of monocytechemotactic protein-induced protein 1 in microglia

Polymorphic regulation of mitochondrial fission and fusion modifies phenotypes of microglia in neuroinflammation

Nuclear presence of nuclear factor of activated T cells (NFAT) c3 and c4 is required for Toll-like receptor-activated innate inflammatory response of monocytes/macrophages

Interferon Regulatory Factor 5 Mediates Lipopolysaccharide-Induced Neuroinflammation

Mitochondrial transcription factor A (Tfam) is a pro-inflammatory extracellular signaling molecule recognized by brain microglia

Modulations of Proinflammatory Cytokines by NF-kappaB and JNK in HAPI Cells Treated with a New TLR4 Agonist KDO2

MicroRNA-92a Negatively Regulates Toll-like Receptor (TLR)-triggered Inflammatory Response in Macrophages by Targeting MKK4 Kinase

TRAF6-p38/JNK-ATF2 Axis Promotes Microglial Inflammatory Activation

Pattern recognition receptors mediate pro-inflammatory effects of extracellular mitochondrial transcription factor A (TFAM)

TRAF6-p38/JNK-ATF2 axis promotes microglial inflammatory activation.

Macropinosomes host TLR9 signaling and regulation of inflammatory responses in microglia

New mitochondrial DNA synthesis enables NLRP3 inflammasome activation

A novel mechanism for NLRP3 inflammasome activation

Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NO-mediated decreases in mitochondrial and cellular function

p38 MAPK inhibits autophagy and promotes microglial inflammatory responses by phosphorylating ULK1

TRAF3-interacting JNK-activating Modulator Promotes Inflammation by Stimulating Translocation of Toll-like Receptor 4 to Lipid Rafts

The role of ZC3H12D-regulated TLR4-NF-κB pathway in LPS-induced pro-inflammatory microglial activation

Mitochondria drive microglial NRLP3 inflammasome activation via TSPO

Chronic TLR Stimulation Controls NLRP3 Inflammasome Activation Through IL-10 Mediated Regulation of NLRP3 Expression and Caspase-8 Activation